Wyeth Announces it Will Eliminate 1,200 Jobs

According to a post on the Wall Street Journal Health blog, Wyeth announced today that it is laying off about 1,200 marketing and sales representatives who helped support Protonix, its blockbuster heartburn and acid reflux medication. The job cuts are part of a previously announced “asset reallocation plan” that is designed to reduce the size of the company’s workforce by about 5% this year, and by 10% over the next three years.

The company employees about 50,000 people worldwide with roughly half of them in the U.S.  Like some of its competitors, Wyeth is facing stiff generic competition for several products that are slated to lose patent protection over the next couple of years and recently has had trouble getting many of its new drugs approved by the US Food and Drug Administration.

Until next time….

Good Luck and Good Job Hunting!!!!!!!!!!!

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.biojobblog.com/admin/trackback/66169
Comments (1) Read through and enter the discussion with the form at the end
healthcare lean training - March 28, 2008 3:29 PM

Thank you very much for a fine read. Keep up the good work and I look forward to reading your posts in the future.

Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.